NANOVELOS - Drug Release Control Technology offered by NanoVelos demonstrates its power by transforming generics to super-generics via an innovative delivery system: they exhibit dramatically improved tumor targeting, thereby enhancing therapy efficacy while minimizing adverse effects on healthy tissues. Nanovelos offers also an adaptation of its proprietary drug delivery system for your anticancer drug. We can conjugate highly potent drugs that struggle to enter preclinical or clinical trials due to the intolerable toxicity or fast clearance.